About us

LaCAR is a Belgian company that was created in Liège in December 2013 by various stakeholders from Liège's economic and scientific networks. The development of LaCAR was carried out in collaboration with the genetic unit of the University of Liège, which displays an international reputation and extensive expertise in the detection of genetic diseases.

LaCAR achieves CE-IVD ISO 13485 certification for its first kit, marking a significant milestone in its commitment to quality and compliance with international standards.

LaCAR extends its reach internationally by exporting its products throughout Europe, consolidating its position as a key player in the field of diagnostic solutions.

The acquisition of Biosense has enabled us to establish a presence in Italy, allowing us to participate in public tenders. This step aligns perfectly with our commitment to expansion.

ZenTech is a Belgian company specialised in newborn screening since 2001. In 2022, LaCAR and ZenTech merged their activities to combine their expertise in in vitro diagnostics (IVD) and their in-depth knowledge of the market.

Based in the U.S., Baebies is known for its innovations in newborn screening, particularly with its SEEKER solution dedicated to detecting Lysosomal Storage Diseases (LSD). Through this acquisition, LaCAR integrates cutting-edge screening technology, extending the number of diseases screened among newborns across Europe.